Robert Don
Drugs for Neglected Diseases Initiative(CH)
Publications by Year
Research Areas
Trypanosoma species research and implications, Research on Leishmaniasis Studies, Synthesis and Biological Evaluation, Parasites and Host Interactions, HIV/AIDS drug development and treatment
Most-Cited Works
- → SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis(2011)296 cited
- → New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients(2009)158 cited
- → Development of Novel Drugs for Human African Trypanosomiasis(2011)137 cited
- → Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis(2012)104 cited
- → Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis(2010)102 cited
- → A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis(2015)100 cited
- → Potential Drug Development Candidates for Human Soil-Transmitted Helminthiases(2011)95 cited
- → Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi(2014)92 cited
- → Benzoxaboroles: A New Class of Potential Drugs for Human African Trypanosomiasis(2011)87 cited
- → Towards a fourth generation R&D management model-research networks in knowledge management(1999)75 cited